| 1 |
34768908 | Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy. | 2021 Oct 25 |
2 |
| 2 |
31658420 | Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding. | 2020 Feb 27 |
1 |
| 3 |
29343861 | Sensing Native Protein Solution Structures Using a Solid-state Nanopore: Unraveling the States of VEGF. | 2018 Jan 17 |
1 |
| 4 |
27898513 | Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex. | 2017 Sep |
6 |
| 5 |
28279966 | Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro. | 2017 May |
1 |
| 6 |
27564657 | Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules. | 2016 Oct |
1 |
| 7 |
25569517 | Plasmin regulation through allosteric, sulfated, small molecules. | 2015 Jan 5 |
1 |
| 8 |
20445443 | Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase. | 2010 Jul |
2 |
| 9 |
19158842 | Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97. | 2009 Jul |
1 |
| 10 |
19712047 | Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage. | 2009 Oct 23 |
2 |
| 11 |
15917224 | Characterization of the interaction between tumor necrosis factor-stimulated gene-6 and heparin: implications for the inhibition of plasmin in extracellular matrix microenvironments. | 2005 Jul 22 |
2 |
| 12 |
14995994 | Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin. | 2004 Feb |
1 |
| 13 |
15203110 | Identification of heparin affin regulatory peptide domains with potential role on angiogenesis. | 2004 Oct |
1 |
| 14 |
15726889 | Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride. | 2004 Oct-Dec |
3 |
| 15 |
12606025 | Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G. | 2003 Feb 27 |
1 |
| 16 |
12877576 | Ionic modulation of the effects of heparin and 6-aminohexanoic acid on plasminogen activation by streptokinase: the role of ionic strength, divalent cations and chloride. | 2003 Apr-Jun |
5 |
| 17 |
14574072 | Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor. | 2003 Feb |
1 |
| 18 |
11711550 | Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. | 2002 Jan 25 |
2 |
| 19 |
11389981 | Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. | 2001 May 14 |
1 |
| 20 |
11806242 | Ectodomain shedding of VEGF183, a novel isoform of vascular endothelial growth factor, promotes its mitogenic activity in vitro. | 2001 |
2 |
| 21 |
30429724 | Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure. | 2001 Jul |
1 |
| 22 |
11113279 | Inhibition of plasmin activity by sulfated polyvinylalcohol-acrylate copolymers. | 2000 Nov 15 |
1 |
| 23 |
10496984 | Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. | 1999 Oct 1 |
1 |
| 24 |
9374687 | Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218). | 1997 Nov |
1 |
| 25 |
8631822 | The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. | 1996 Mar 29 |
1 |
| 26 |
7569739 | Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children. | 1995 Jul |
2 |
| 27 |
7574939 | Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. | 1995 Oct |
1 |
| 28 |
7534486 | Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors. | 1994 Dec |
4 |
| 29 |
7952425 | Lack of degradation of antithrombin III by tissue-type plasminogen activator or plasmin. | 1994 Jul |
1 |
| 30 |
8231204 | Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. | 1993 Nov |
1 |
| 31 |
8452552 | Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase. | 1993 Mar 1 |
1 |
| 32 |
1376317 | Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. | 1992 Jun 15 |
2 |
| 33 |
1387549 | N-oleoyl heparin inhibits the amidolytic activity of plasmin and urokinase. | 1992 Apr |
1 |
| 34 |
1720904 | Limited proteolysis of vitronectin by plasmin destroys heparin binding activity. | 1991 Sep 2 |
1 |
| 35 |
1833087 | Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase. | 1991 Oct |
1 |
| 36 |
1700488 | Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin. | 1990 Aug 1 |
2 |
| 37 |
2116167 | Tissue plasminogen activator catalyzed Lys-plasminogen activation on heparin-inserted phospholipid liposomes. | 1990 May 29 |
1 |
| 38 |
2139798 | Co-immobilization and interaction of heparin and plasmin on collageno-elastic tubes. | 1990 |
12 |
| 39 |
2143417 | Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. | 1990 Jun 26 |
1 |
| 40 |
2479114 | Stimulation of plasmin catalyzed conversion of single-chain to two-chain urokinase-type plasminogen activator by sulfated polysaccharides. | 1989 Sep 29 |
2 |
| 41 |
2534055 | [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis]. | 1989 Nov |
5 |
| 42 |
2451918 | Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. | 1988 Apr 15 |
1 |
| 43 |
2956994 | Conditions of formation of the heparin-fibronectin-collagen complex and the effect of plasmin. | 1987 Sep 11 |
1 |
| 44 |
2943315 | Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. | 1986 Jul 15 |
4 |
| 45 |
2945283 | Stimulation by heparin of the plasmin-mediated conversion of single-chain to two-chain urokinase-type plasminogen activator. | 1986 Sep 15 |
1 |
| 46 |
2935971 | Proteolysis of histidine-rich glycoprotein in plasma and in patients undergoing thrombolytic therapy. | 1985 Dec 1 |
1 |
| 47 |
2944348 | Sensitivity of thrombin and plasmin to heparin and antithrombin III. | 1985 |
1 |
| 48 |
4008652 | Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. | 1985 Jun |
1 |
| 49 |
6198531 | Current status of pulmonary thromboembolism--incidence, diagnosis, classification, pathogenesis, and treatment. | 1984 Jan |
1 |
| 50 |
6222929 | The interaction of heparin with human plasmin. | 1983 |
7 |